Details of the Drug Reposition

General Information of This Drug (ID: DMEMBJC)

• Drug Name: Folic Acid (DMEMBJC)
• Synonyms: folic acid; 59-30-3; Folate; Pteroylglutamic acid; Vitamin M; Folacin; Folacid; PteGlu; Vitamin B9; Folvite; Pteroyl-L-glutamic acid; Vitamin Bc; Acifolic; Cytofol; Incafolic; Foliamin; Folsaure; Folicet; Millafol; Folipac; Folettes; Folsan; Folbal; Folsav; Vitamin Be; Pteroyl-L-monoglutamic acid; Mittafol; Folan; Facid; Pteroylmonoglutamic acid; Antianemia factor; Factor U; Folico (Italy); Folina (Italy); Foldine [France]; Pteroylmonoglutamate; Acfol (Spain); Foldine; Folcysteine; Folasic (Australia); Folcidin; Folaemin [Netherlands]; Nifolin; [3H]folic acid
• Therapeutic Class: Vitamins
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

9 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Colorectal carcinoma	DIS5PYL0	N.A.	Approved	[1]
Inflammation	DISJUQ5T	1A00-CA43.1	Approved	[1]
Coronavirus Disease 2019 (COVID-19)	DISM7GNX	1D6Y	Approved	[2]
Lung cancer	DISCM4YA	2C25.0	Approved	[1]
Iron-deficiency anemia	DIS0VQYF	3A00	Approved	[1]
Folate-deficiency anemia	DISG00K2	3A02.Y	Approved	[1]
Vitamin deficiency	DISD07I9	5B55-5B71	Approved	[1]
Pervasive developmental disorder	DIS51975	6A00-6A0Z	Approved	[1]
Infertility	DISAMOWP	GB04	Approved	[1]

References

• [1] Folic acid FDA Label
• [2] ClinicalTrials.gov (NCT04354428) Treatment for COVID-19 in High-Risk Adult Outpatients. U.S. National Institutes of Health.